Myriad Genetics
MYGN
#6699
Rank
NZ$1.14 B
Marketcap
NZ$12.27
Share price
-3.27%
Change (1 day)
-55.87%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2025 (TTM): -NZ$0.7 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are NZ$0.82 Billion. In 2024 the company made an earning of -NZ$0.21 Billion, an increase over its 2023 earnings that were of -NZ$0.45 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.7 Billion234.05%
2024 -NZ$0.21 Billion-53.49%
2023 -NZ$0.45 Billion88.72%
2022 -NZ$0.24 Billion172.08%
2021 -NZ$87.42 Million
2019 -NZ$45.53 Million-175.14%
2018 NZ$60.58 M-70.81%
2017 NZ$0.20 B22.22%
2016 NZ$0.16 B-38.8%
2015 NZ$0.27 B-6.12%
2014 NZ$0.29 B-41.07%
2013 NZ$0.50 B46.67%
2012 NZ$0.34 B15.84%
2011 NZ$0.29 B17.6%
2010 NZ$0.25 B-15.96%
2009 NZ$0.29 B
2007 -NZ$72.15 Million40.96%
2006 -NZ$51.18 Million
2003 -NZ$59.44 Million34.8%
2002 -NZ$44.09 Million89.21%
2001 -NZ$23.31 Million3.93%
2000 -NZ$22.43 Million21.76%
1999 -NZ$18.42 Million-25.61%
1998 -NZ$24.76 Million38.83%
1997 -NZ$17.83 Million-24.26%
1996 -NZ$23.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Bio-Rad Laboratories
BIO
-NZ$1.46 Billion 101.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-NZ$1.68 Billion 131.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-NZ$60.53 Million-91.64%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$1.17 B-262.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$14.08 B-2,044.56%๐Ÿ‡บ๐Ÿ‡ธ USA